UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase I study of palbociclib, a cyclin‐dependent kinase 4/6 inhibitor, in Japanese patients

Cancer science, 2016-06, Vol.107 (6), p.755-763

2016

Volltextzugriff (PDF)

A first-in-human Phase 1 study of epirubicin-conjugated polymer micelles (K-912/NC-6300) in patients with advanced or recurrent solid tumors

Investigational new drugs, 2017-06, Vol.35 (3), p.307-314

2017

Volltextzugriff (PDF)

Randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer

Breast (Edinburgh), 2021-02, Vol.55, p.63-68

2021

Volltextzugriff (PDF)

Patritumab plus trastuzumab and paclitaxel in human epidermal growth factor receptor 2‐overexpressing metastatic breast cancer

Cancer science, 2016-10, Vol.107 (10), p.1465-1470

2016

Volltextzugriff (PDF)

Japanese phase I study of cabazitaxel in metastatic castration-resistant prostate cancer

International journal of clinical oncology, 2015-10, Vol.20 (5), p.1026-1034

2015

Volltextzugriff (PDF)

Quality of life in a randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer

Breast cancer (Tokyo, Japan), 2022-01, Vol.29 (1), p.131-143

2022

Volltextzugriff (PDF)

Effect of food on the pharmacokinetics of TAS‐102 and its efficacy and safety in patients with advanced solid tumors

Cancer science, 2016-05, Vol.107 (5), p.659-665

2016

Volltextzugriff (PDF)

Excision Repair Cross-Complementing Group 1 May Predict the Efficacy of Chemoradiation Therapy for Muscle-Invasive Bladder Cancer

Clinical cancer research, 2011-04, Vol.17 (8), p.2561-2569

2011

Volltextzugriff (PDF)

Survival outcome and reduction rate of Ki-67 between pre- and post-neoadjuvant chemotherapy in breast cancer patients with non-pCR

Breast cancer research and treatment, 2014-08, Vol.147 (1), p.95-102

2014

Volltextzugriff (PDF)

Evidence-based guidelines for treatment of uterine body neoplasm in Japan: Japan Society of Gynecologic Oncology (JSGO) 2009 edition

International journal of clinical oncology, 2010-12, Vol.15 (6), p.531-542

2010

Volltextzugriff (PDF)

Pathologic complete response after neoadjuvant chemotherapy in HER2-overexpressing breast cancer according to hormonal receptor status

Breast (Edinburgh), 2014-08, Vol.23 (4), p.466-472

2014

Volltextzugriff (PDF)

Soy‐derived isoflavones inhibit the growth of adult T‐cell leukemia cells in vitro and in vivo

Cancer science, 2007-11, Vol.98 (11), p.1740-1746

2007

Volltextzugriff (PDF)

Intestinal Perforation due to Neutropenic Enterocolitis in a Patient Treated with Bevacizumab for Ovarian Cancer

Case reports in oncological medicine, 2020-01, Vol.2020 (2020), p.1-4

2020

Volltextzugriff (PDF)

Correction to: Quality of life in a randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer

Breast cancer (Tokyo, Japan), 2022, Vol.29 (1), p.186-188

2022

Volltextzugriff (PDF)

Phase 1 combination study of Eribulin mesylate with trastuzumab for advanced or recurrent human epidermal growth factor receptor 2 positive breast cancer

Investigational new drugs, 2015-02, Vol.33 (1), p.119-127

2015

Volltextzugriff (PDF)

Elderly Breast Cancer Therapy: A Japanese Experience

Japanese journal of clinical oncology, 2010-08, Vol.40 (8), p.717-721

2010

Volltextzugriff (PDF)

Comparison between neoadjuvant and adjuvant gemcitabine plus cisplatin chemotherapy for muscle-invasive bladder cancer

Asia-Pacific journal of clinical oncology, 2013-12, Vol.9 (4), p.310-317

2013

Volltextzugriff (PDF)

Use of eribulin as an earlier-line chemotherapy for patients with HER2-negative metastatic breast cancer

Journal of Cancer, 2020-01, Vol.11 (14), p.4099-4105

2020

Volltextzugriff (PDF)

Circulating Hematopoietic Progenitors in Patients with Primary Lung Cancer

Cancer science, 1990-12, Vol.81 (12), p.1293-1299

1990

Volltextzugriff (PDF)

Effect of chemotherapy on colony-forming unit-granulocyte macrophage from bone marrow and peripheral blood in patients with lung cancer

Oncology, 1992, Vol.49 (1), p.45-48

1992

Volltextzugriff (PDF)

Pharmacokinetics of bronchial artery infusion of mitomycin in patients with non-small cell lung cancer

European journal of cancer & clinical oncology, 1991-01, Vol.27 (8), p.1046-1048

1991

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase I study of palbociclib, a cyclin‐dependent kinase 4/6 inhibitor, in Japanese patients

A first-in-human Phase 1 study of epirubicin-conjugated polymer micelles (K-912/NC-6300) in patients with advanced or recurrent solid tumors

Randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer

Patritumab plus trastuzumab and paclitaxel in human epidermal growth factor receptor 2‐overexpressing metastatic breast cancer

Japanese phase I study of cabazitaxel in metastatic castration-resistant prostate cancer

Quality of life in a randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer

Effect of food on the pharmacokinetics of TAS‐102 and its efficacy and safety in patients with advanced solid tumors

Excision Repair Cross-Complementing Group 1 May Predict the Efficacy of Chemoradiation Therapy for Muscle-Invasive Bladder Cancer

Survival outcome and reduction rate of Ki-67 between pre- and post-neoadjuvant chemotherapy in breast cancer patients with non-pCR

The efficacy and toxicity of cabazitaxel for treatment of docetaxel-resistant prostate cancer correlating with the initial doses in Japanese patients

Evidence-based guidelines for treatment of uterine body neoplasm in Japan: Japan Society of Gynecologic Oncology (JSGO) 2009 edition

Pathologic complete response after neoadjuvant chemotherapy in HER2-overexpressing breast cancer according to hormonal receptor status

Soy‐derived isoflavones inhibit the growth of adult T‐cell leukemia cells in vitro and in vivo

Intestinal Perforation due to Neutropenic Enterocolitis in a Patient Treated with Bevacizumab for Ovarian Cancer

Correction to: Quality of life in a randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer

Phase 1 combination study of Eribulin mesylate with trastuzumab for advanced or recurrent human epidermal growth factor receptor 2 positive breast cancer

Elderly Breast Cancer Therapy: A Japanese Experience

Comparison between neoadjuvant and adjuvant gemcitabine plus cisplatin chemotherapy for muscle-invasive bladder cancer

Use of eribulin as an earlier-line chemotherapy for patients with HER2-negative metastatic breast cancer

Circulating Hematopoietic Progenitors in Patients with Primary Lung Cancer

Effect of chemotherapy on colony-forming unit-granulocyte macrophage from bone marrow and peripheral blood in patients with lung cancer

Pharmacokinetics of bronchial artery infusion of mitomycin in patients with non-small cell lung cancer

Aktive Filter

Suchergebnisse filtern